All sponsors

Ribocure Pharmaceuticals AB

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS5
PHASE 3 / 2-30
RECRUITING1
READOUTS ≤12 MONTHS3
Open Ribocure Pharmaceuticals AB on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
RBD1016
NCT06649266
P2Active, not recruitingChronic Hepatitis D142026-09-24 (+4 mo)
RBD5044
NCT06797401
P2RecruitingDyslipidemias1202027-05-31 (+12 mo)
Vortosiran
NCT07850453
P2Not yet recruitingVenous Thromboembolism (VTE); Cancer1502027-07
RBD1119
NCT07884136
P2Not yet recruitingStable Coronary Artery Disease2002027-09-30
Vortosiran
NCT07870889
P2Not yet recruitingNon-valvular Atrial Fibrillation (AF)1502028-07-31